Michael L. Meyers Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Michael L. Meyers is SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 23,280 shares of SNDX, which is worth approximately $525,429. The most recent transaction as insider was on Jan 31, 2022, when has been sold 1,714 shares (Common Stock) at a price of $12.39 per share, resulting in proceeds of $21,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
0% 3M change
0% 12M change
Total Value Held $525,429

Michael L. Meyers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2022
BUY
Other acquisition or disposition
$21,236 $12.39 p/Share
1,714 Added 6.86%
23,280 Common Stock
Dec 30 2021
BUY
Exercise of conversion of derivative security
$51,743 $8.77 p/Share
5,900 Added 21.48%
21,566 Common Stock
Apr 26 2021
BUY
Open market or private purchase
$7,730 $15.46 p/Share
500 Added 3.09%
15,666 Common Stock
Jan 31 2021
BUY
Other acquisition or disposition
$21,252 $12.0 p/Share
1,771 Added 10.46%
15,166 Common Stock
Jul 31 2020
BUY
Other acquisition or disposition
$21,240 $7.97 p/Share
2,665 Added 16.59%
13,395 Common Stock

Also insider at

NUVL
Nuvalent, Inc. Healthcare
MLM

Michael L. Meyers

SVP, Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX